Skip to content Skip to filters

Switch field

World Wide home
All fields

Drug Repurposing

Nearby fields

Pharmacology
Clinical Pharmacology
Cheminformatics
Neuropharmacology
Psychopharmacology
Computational Chemistry

PostPostSign in Sign up

Switch field

World Wide home
All fields

Drug Repurposing

Nearby fields

Pharmacology
Clinical Pharmacology
Cheminformatics
Neuropharmacology
Psychopharmacology
Computational Chemistry

Overview
Seminars
Jobs
Funding
Recorded talks
ePosters
People

Map

We use cookies for analytics.

Overview
Seminars
Jobs
Funding
Recorded talks
ePosters
People

Map

Friday 13 November 2026 · times in UTC

Drug Repurposing

Topics

AlphaFold
CSF
immune markers
immune system
movement disorders
neuropathology
translational research
CACNA1A
ataxia
caffeine

Opportunities

Career stage

Jobs

Today
Doctoral Researcher (PhD) in Protein Synthesis
University of Helsinki · Helsinki, Finland
Closes Nov 13

Funding

Today
BRING IT — Brain Research & Innovation Network: Grant Initiative of Texas
Rainwater Charitable Foundation · Grant
Closes Nov 13
2 days left
2026 Royal Society of Tasmania Doctoral Awards
Royal Society of Tasmania · Award · Open to all fields
Closes Nov 15
5 days left
UKRI Translation: MRC Proof of Concept: stage one
Medical Research Council (MRC) · Grant
Closes Nov 18

All funding →

Latest

ePosterAdded Apr 24
Understanding the pathogenic mechanisms underlying a rare genetic form of hereditary spastic paraplegia (aka SINO syndrome) caused by mutations in the KIDINS220 gene
Alicja Krawczun-Rygmaczewska, Matteo Rossi Sebastiano, Filippo Santorelli, Giulia Caron, Giuseppe Ermondi, Fabio Benfenati, Fabrizia Cesca
ePosterAdded Apr 24
ZBTB20 haploinsufficiency causes autism-like behavior in mice and can partially be improved by erythropoietin
Martin Hindermann
RecordingRecorded May 30, 2023CSFimmune markers
Immunosuppression for Parkinson's disease - a new therapeutic strategy?
Caroline Williams-Gray · University of Cambridge
RecordingRecorded Dec 14, 20206-hydroxydopamineL-DOPA
What about antibiotics for the treatment of the dyskinesia induced by L-DOPA?
Elaine Del-Bel · School of Dentistry, Ribeirão Preto (FORP), University of São Paulo.

Recordings →
ePosters →

Related fields

Pharmacology
Clinical Pharmacology
Cheminformatics
Neuropharmacology
Psychopharmacology
Computational Chemistry

© 2026 World Wide · Operated by Science Communications Worldwide (Austria)

About
Contact
Status
Imprint
Privacy
Cookies
Terms
Accessibility